Breaking News Bar

Business News and Information

Biotech stocks get 2.4% boost from Amgen’s $10.4B purchase of Onyx

Biotech stocks as a whole were up Monday following news of Amgen’s $10.4 billion deal to buy South San Francisco-based Onyx Pharmaceuticals Inc...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear